A. Beynarovich

Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma

I. Moiseev, A. Kozlov, K. Lepik, 2021, International Journal of Clinical Oncology.

Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine–bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma

L. Stelmakh, I. Moiseev, B. Afanasyev, 2022, International Journal of Hematology.

A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma

L. Stelmakh, I. Moiseev, B. Afanasyev, 2020, HemaSphere.

Graft-versus-host disease prophylaxis with posttransplantation bendamustine (PTB) in patients with refractory acute leukemia: a dose-ranging study: Category of manuscript: Regular Manuscript.

E. Surkova, I. Moiseev, S. Bondarenko, 2021, Transplantation and cellular therapy.

Haploidentical stem cell transplantation in adults for the treatment of hematologic diseases : results of a single center ( CIC 725 ) Cellular

I. Moiseev, B. Afanasyev, S. Bondarenko, 2019 .